In recent years, American hospitals have made significant improvements on standardized, evidence-based measures of clinical performance for several medical conditions, including heart attacks, heart failure, and pneumonia. But an editorial, published in the July 21 issue of the New England Journal of Medicine, says it’s not clear how much effect these improvements in patient care have had on public health, especially in reducing morbidity and mortality. The editorial, authored by Patrick S. Romano, professor of general medicine at UC Davis School of Medicine and Medical Center, is published along with two new quality-of-care studies.
"Evaluating how hospitals deliver medical care does standardize practices and improve care," says Romano. "For example, hospitals are now more likely to give aspirin and beta blockers to heart attack patients, to evaluate heart failure patients appropriately, to provide complete instructions when patients go home, and to counsel smokers to quit. But we do not yet have evidence that these improvements are reducing morbidity and mortality from heart disease, heart failure and pneumonia."
In the editorial, Romano analyzes two studies that used standardized, evidence-based measure to evaluate and improve hospitals’ quality of care. One study, from the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), describes results from a program in which hospitals seeking accreditation were required to collect and submit data on clinical performance on 18 measures for acute myocardial infarction, heart failure and pneumonia. The other, from the Centers for Medicare and Medicaid Services (CMS), reports on several of the same measures as the JCAHO study.
Carole Gan | EurekAlert!
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences